Paid Clinical Trials in Newnan, GA
As of July 2026, 51 paid clinical trials are recruiting in Newnan, Georgia. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Newnan offers studies at sites including CTCA at Southeastern Regional Medical Center for conditions such as Chronic Lymphocytic Leukemia, Multiple Myeloma, Small Lymphocytic Lymphoma, Stage IIIB Lung Cancer AJCC v8. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Newnan
Trials by drug in Newnan
Filter results
50 clinical trials
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Freedom-1 Study for Chronic Knee Pain
Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer
Shoulder Innovations Clinical Data Registry
A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma
Post-Market Clinical Study of Functional Motion Outcomes in Subjects Treated With the Minuteman Device
Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3
Epcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell Transplant for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
Top Research Study Locations in Newnan
Researchers run research studies in Newnan, GA at 22 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| CTCA at Southeastern Regional Medical Center | Stage IIIB Lung Cancer AJCC v8, Advanced Lung Non-Small Cell Carcinoma, Extensive Stage Lung Small Cell Carcinoma | 9 |
| City of Hope Atlanta Cancer Center | Advanced Colon Adenocarcinoma, Advanced Colorectal Adenocarcinoma, Advanced Rectal Adenocarcinoma | 7 |
| Southeastern Regional Medical Center | Follicular Lymphoma, B-cell Malignancy, Chronic Lymphocytic Leukemia | 4 |
| City of Hope Atlanta | Extensive Stage Small-cell Lung Cancer, Hodgkin Lymphoma, Lymphoma | 3 |
| City of Hope National Medical Center, Atlanta Cancer Center | Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Chronic Lymphocytic Leukemia | 3 |
| Piedmont Newnan Hospital | Breast Cancer, Grade 2 Meningioma, Intracranial Meningioma | 3 |
| City of Hope Cancer Center | Carcinoma, Non-Small-Cell Lung, Multiple Myeloma | 2 |
| Southeastern Regional Medical Center, Inc. dba City of Hope Atlanta | Relapsed or Refractory Large B-cell Lymphoma, Triple Negative Breast Cancer | 2 |
| Vista Clinical Research | Degenerative Conditions of the Lumbar Spine, Lumbar Spinal Stenosis, Spondylolisthesis | 2 |
| Ambros Clinical Trial Site | Complex Regional Pain Syndrome Type I | 1 |
| Cancer Treatment Ctrs of America At | Lumbar Spinal Stenosis | 1 |
| City Of Hope - Atlanta. | Multiple Myeloma | 1 |
| City of Hope - Atlanta | Hematologic Malignancies | 1 |
| City of Hope - Cancer Center Atlanta | Breast Cancer | 1 |
| City of Hope 1 | Carcinoma, Non-small-Cell Lung | 1 |
| City of Hope Cancer Center - Atlanta | Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms, Triple Negative Breast Neoplasms | 1 |
| City of Hope at Georgia - Atlanta | Lung Carcinoma | 1 |
| City of Hope® Atlanta | KRAS G12C Lung Cancer, Non-Small Cell Lung Cancer | 1 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC) | 1 |
| Georgia Bone and Joint | Shoulder Arthroplasty | 1 |
| Georgia Pain and Spine Care | Lumbar Spinal Stenosis | 1 |
| Vista Clinical Research/Summit Spine & Joint Centers | Osteoarthritic Knee Pain | 1 |
Active & Upcoming Studies in Newnan (2026)
Recruiting trials in Newnan grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (41 active studies)
- Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3 · Phase 2 · City of Hope Medical Center
- Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial · Phase 3 · City of Hope Medical Center
Neurology & pain (2 active studies)
- Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE) · Phase 3 · Ambros Therapeutics, Inc.
- Freedom-1 Study for Chronic Knee Pain · Curonix LLC
Common conditions studied in Newnan
- Chronic Lymphocytic Leukemia (3 active studies)
- Multiple Myeloma (3 active studies)
- Small Lymphocytic Lymphoma (3 active studies)
- Stage IIIB Lung Cancer AJCC v8 (3 active studies)
- Breast Cancer (2 active studies)
- Breast Neoplasms (2 active studies)
Leading research sponsors in Newnan
- City of Hope Medical Center
- NRG Oncology
- National Cancer Institute (NCI)
- Amgen
- AstraZeneca
Frequently asked questions
How many paid clinical trials are currently recruiting in Newnan?
There are approximately 51 recruiting clinical trials in Newnan, Georgia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Newnan pay participants?
Most recruiting trials in Newnan compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Newnan?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Newnan?
The most common conditions under active study in Newnan include Chronic Lymphocytic Leukemia (3), Multiple Myeloma (3), Small Lymphocytic Lymphoma (3), Stage IIIB Lung Cancer AJCC v8 (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Newnan?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Newnan on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Newnan?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Newnan?
Recruiting research sites in Newnan include CTCA at Southeastern Regional Medical Center, City of Hope Atlanta Cancer Center, Southeastern Regional Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Newnan right now?
The largest active categories in Newnan are Cancer & tumors (41), Neurology & pain (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.